Ivor Elrifi is CEO at Tiziana Life Sciences Ltd (TLSA). They have made 2 open-market trades across 1 company since 2026, most recently 2026-08-15.
CIK 0002136241
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $986K since 2026, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TLSA | 5,843,684 | $5.9M |
Shares reported on the most recent Form 4, priced at the 2026-09-29 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.